高风险患者群体皮肤状细胞癌的瘤微环境:范围审查
Wandong Wang1, Clara Harrs2, Maria C Bolling1
1Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
概括
在器官移植接受者和衰退性 Dystrophic Epidermolysis Bullosa 患者的高风险皮肤状细胞癌 (cSCC) 显示出明显的瘤微环境. 了解这些差异可以指导针对攻击性cSCC的向治疗.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 皮肤状细胞癌 (cSCC) 是常见的,但在器官移植接受者和衰退性缩性表皮溶解患者中具有侵略性.
- 瘤微环境显著影响cSCC的进展,免疫逃避和治疗反应.
- 与零星形式相比,高风险cSCC带来了独特的挑战.
研究的目的:
- 系统地审查和比较高风险cSCC的瘤微环境 (器官移植接受者,衰退性缩性表皮溶解) 与零星的cSCC.
- 确定高风险cSCC的共享瘤发生机制和知识差距.
- 探索瘤微环境中的潜在治疗点.
主要方法:
- 覆盖范围审查方法.
- 系统地调查免疫细胞透,上皮细胞-介质细胞过渡和细胞外矩阵重塑.
- 对相关生物标志物和治疗目标的分析.
主要成果:
- 高风险的cSCC可能具有允许的瘤微环境,具有免疫功能障碍和增强的TGFβ信号传递.
- 器官移植接受者cSCC主要表现为免疫衰竭.
- 衰退性 Dystrophic Epidermolysis Bullosa cSCC 的特点是慢性组织损伤和细胞外矩阵重塑.
结论:
- 独特的瘤微环境有助于高风险人群中cSCC的攻击性.
- 针对特定微环境特征的向治疗可以改善这些患者的治疗结果.
- 对这些独特的瘤微环境的进一步研究对于开发新疗法至关重要.
相关概念视频
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:17The Tumor Microenvironment
3.0K
3.0K
01:30Skin Cancer
6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K